Calcium gluconate and Neurotoxicity - a phase IV clinical study of FDA data

Summary:

Neurotoxicity is reported as a side effect among people who take Calcium gluconate (calcium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Fever.

The phase IV clinical study analyzes which people have Neurotoxicity when taking Calcium gluconate. It is created by eHealthMe based on reports of 6,160 people who have side effects when taking Calcium gluconate from the FDA, and is updated regularly.

What is Calcium gluconate?

Calcium gluconate has active ingredients of calcium. eHealthMe is studying from 6,181 Calcium gluconate users. Check the latest studies of Calcium gluconate.

What is Neurotoxicity?

Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system) is found to be associated with 683 drugs and 846 conditions by eHealthMe. Check the latest studies of Neurotoxicity.

On Jul, 13, 2026

6,160 people reported to have side effects when taking Calcium gluconate.
Among them, 26 people (0.42%) have Neurotoxicity.

Could Calcium gluconate cause Neurotoxicity?

Among these 26 people:

How long have people been on Calcium gluconate when they have Neurotoxicity? *

What is the gender of people who have Neurotoxicity when taking Calcium gluconate? *

female: 13.64 %
male: 86.36 %

What is the age of people who have Neurotoxicity when taking Calcium gluconate? *

What are other drugs people take besides Calcium gluconate? *

What are other side effects people have besides Neurotoxicity? *

Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 8 people, 30.77%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 23.08%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 6 people, 23.08%
Hypokalemia (low potassium): 6 people, 23.08%
Myelosuppression (a decrease in the production of blood cells): 5 people, 19.23%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 5 people, 19.23%
Blood Glucose Increased: 5 people, 19.23%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 5 people, 19.23%
Speech Impairment (Adult) (inability to speak (adult)): 3 people, 11.54%
Enterococcal Infection: 2 people, 7.69%

What are the existing conditions these people have? *

Fever: 7 people, 26.92%
Pain: 6 people, 23.08%
Hepatic Function Abnormal: 6 people, 23.08%
Hepatic Steatosis (fatty liver disease): 6 people, 23.08%
Pneumonia: 6 people, 23.08%
Hepatitis Viral: 6 people, 23.08%
Lymphoma (cancer that begins in immune system cells): 6 people, 23.08%
Hypersensitivity: 6 people, 23.08%
Nausea And Vomiting: 5 people, 19.23%
Hypoproteinaemia (too little prolactin circulating in the blood): 5 people, 19.23%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium gluconate and have Neurotoxicity?

- Check whether Neurotoxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Calcium gluconate:

Calcium gluconate (6,181 reports)

Neurotoxicity treatments and more:

Neurotoxicity (16,742 reports)

Browse all side effects of Calcium gluconate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neurotoxicity:

Neurotoxicity (683 drugs)

Browse all the conditions that are associated with Neurotoxicity:

Neurotoxicity (846 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcium (the active ingredients of Calcium gluconate) and Calcium gluconate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.